U.S. healthcare is now a solid week into the CT contrast shortage of ’22, and common themes are emerging in adaptations at local hospitals and imaging centers.

The exterior illuminations are only one part of the ALA’s annual “Turquoise Takeover” initiative. Also look for turquoise accents across social media, including in the apparel choices of enthusiasts posting selfies.

In some cases hospital staff kept no watch over outside-looking-in connections between manufacturers and scanners.

Computer scientists, rheumatologists and immunologists have pooled skill sets to develop a neural network that can distinguish between rheumatoid and psoriatic arthritis while also recognizing healthy joints with no arthritis at all.

Outside of the correlation between measurements obtained using both modalities, the researchers also identified Hounsfield unit thresholds that could reliably rule out osteoporosis.

A study published this week in Radiology found that 12 months after hospitalization for COVID pneumonia, 93% of patients’ lung abnormalities had cleared up on follow-up chest CT scans.

With the shortage, which pertains specifically to all formulations and concentrations of GE Healthcare’s Omnipaque (iohexol), expected to last until mid-June, several organizations have alluded that conservation efforts are of critical importance.

Leslee Shaw, PhD, director of The Blavatnik Family Women’s Health Research Institute, Mount Sinai Hospital, New York, explains how cardiac computed tomography (CT) can be used to assess coronary plaques.